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Abstract: The amyloid formation of the folded segment of a
variant of Exenatide (a marketed drug for type-2 diabetes
mellitus) was studied by electronic circular dichroism (ECD)
and NMR spectroscopy. We found that the optimum temper-
ature for E5 protein amyloidosis coincides with body tem-
perature and requires well below physiological salt concen-
tration. Decomposition of the ECD spectra and its barycen-
tric representation on the folded-unfolded-amyloid potential
energy surface allowed us to monitor the full range of mo-
lecular transformation of amyloidogenesis. We identified
points of no return (e.g. ; T = 37 8C, pH 4.1, cE5 = 250 mm,
cNaCl = 50 mm, t>4–6 h) that will inevitably gravitate into the
amyloid state. The strong B-type far ultraviolet (FUV)-ECD
spectra and an unexpectedly strong near ultraviolet (NUV)-
ECD signal (V275–285 nm) indicate that the amyloid phase of
E5 is built from monomers of quasi-elongated backbone
structure (f1458, y + 1458) with strong interstrand
Tyr$Trp interaction. Misfolded intermediates and the build-
up of “toxic” early-stage oligomers leading to self-association
were identified and monitored as a function of time. Results
indicate that the amyloid transition is triggered by subtle
misfolding of the a-helix, exposing aromatic and hydropho-
bic side chains that may provide the first centers for an in-
termolecular reorganization. These initial clusters provide
the spatial closeness and sufficient time for a transition to
the b-structured amyloid nucleus, thus the process follows a
nucleated growth mechanism.
Introduction
Aggregation of proteins and peptide segments into amyloid fi-
brils have been studied intensively over the past decades since
the process was shown to be associated with, or even trig-
ger,[1–3] such illnesses as Alzheimer’s disease, type-2 diabetes
mellitus, rheumatoid arthritis, or haemodialysis ass. amyloido-
sis.[4] From the pioneering work on lysozyme[5] and Ab(1–
42),[6–8] the amyloid state of several misfolded proteins (e.g. ,
b2-microglobulin,[9] crystallin,[10] tau protein,[11–13] the glucagon
peptide hormone,[14] and insulin[15] among others) were charac-
terized. The general topology of such aggregates consists of
protein segments adopting an extended backbone, interacting
through b-edges. The association between the b-sheets thus
formed is compact and specific ; in most cases it excludes
water molecules, leading to the formation of tightly stacked,
“dry-zipper” nanostructures.[16–18] The state-of-the-art TEM,
SAXS, cryo-EM and ssNMR techniques now allow full character-
ization of the aggregated end-state;[19, 20] however, much less is
known about the specific molecular species that evolve during
the process, especially in the early stages, which concern the
formation of still soluble but oligomeric assemblies that are
the most toxic[1–3, 21, 22] and also represent the stage at which
amyloidosis can still be reversed.[23]
The progress of self-association can often be followed by
ThT fluorescence and DLS—best in combination[24]—reporting
the accumulation of cross-b-backbone (above a minimum size
of ca. 10 nm or 4–6 aligned strands[25]) and the size distribution
of the species present in the solution, respectively. However, to
gain atomistic detail, molecular spectroscopy needs to be ap-
plied such as CD, IR or NMR spectroscopy.[26, 27] In fact, CD spec-
troscopy can be used to monitor a full range of molecular
transformations accompanying amyloidogenesis if the secon-
dary structure content of the folded, intermediate, and amyloid
states are distinct. There are notable examples that satisfy this
description; namely, helical peptide hormones such as amylin
or glucagon and a considerable number of peptide therapeu-
tics[28] and since over 60 % of all protein-protein interfaces—
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typical targets of drug design—also constitute helices,[29] their
number will most likely just increase.
Here we present the amyloid formation pathway of a variant
of Exenatide, a marketed drug for type-2 diabetes mellitus[30]
that also contains a well-folded a-helix. We have discovered
that this 25 residue long segment (E5: EEEAVRLYIQWL-
KEGGPSSGRPPPS) (Figure 1), comprising the entire interface
needed for GLP-1 receptor binding,[31] can be turned into amy-
loid in a controlled, fully reproducible and tunable manner
within a large range of protein concentrations (80 mm<
cprotein<800 mm) at physiologically relevant temperatures.
Therefore, understanding the molecular details of the amyloi-
dosis of E5 and mapping its conditions is highly relevant to
any optimization efforts targeting Exenatide. In addition, E5 is
an ideal model to study the amyloid transition of folded pro-
teins and helix-containing peptides. Beside its helical stretch,
E5 contains a b-turn, a polyproline-II helix and a hydrophobic
center with a buried Trp, thus has a protein-like build-up and
also folds quite similarly to a typical globular protein.[32]
As E5 is small, both its chemical synthesis on a resin and
bacterial expression in a fusion system is straightforward.[33]
Given that its folded state is partially helical, its transition
toward the amyloid phase results in a significant change in
secondary structure content, which is easy to monitor by elec-
tronic circular dichroism (ECD) spectroscopy. Furthermore, E5
has an interacting Trp/Tyr residue pair within its hydrophobic
core, enabling folding and refolding of the protein to be
tracked by near ultraviolet (NUV)- in addition to far ultraviolet
(FUV)-ECD. We also found the process to be quenchable; the
amyloid formation can be suspended at any time by dropping
the temperature, and restarted by a subsequent temperature
rise. Furthermore, the moderate size of E5 allows detailed
structure characterization both by NMR and modeling tech-
niques.
We probed various regions of the f(T,pH,cprotein,cion,t) potential
energy hypersurface of E5 by acquiring quantitative NUV- and
FUV-ECD chiroptical information and NMR data complemented
by MD simulations to pinpoint the reaction path that leads
from the fully folded- to the amyloid-state. Based on these re-
sults, we were able to propose a mechanism that resembles
that of well-folded proteins but relies on special features of
the miniprotein. The methodology presented here gains signif-
icance because the amyloid state of E5 is ThT silent and thus
presents an approach for dealing with such cases as well.
Results and Discussion
We have shown previously[34] that high concentrations (c10–
30 mm) of E5 trigger self-association, accompanied by an a-
helix to antiparallel b-sheet structural transition. Here, we set
out to identify optimum conditions of aggregation, structurally
characterizing key states along this route at a physiologically
more relevant concentration range using NMR, NUV- and FUV-
ECD data to pinpoint misfolded structures of the reaction
path, and electron microscopy to confirm the emerging amy-
loid fibrils.
To locate roughly and effectively those conditions that
enable the amyloid formation, the HANABI system[35] was ap-
plied. The 96 well plates were set up with the following boun-
daries: 2<pH<7, 80 mm<cE5<800 mm and 0 mm<cNaCl<
100 mm at T = 37 8C. ECD measurements were carried out after
90 h, with sonication cycle turned “on” for 1 min and repeated
every 10 min (power level : 700 W and frequency: 25 kHz). FUV-
ECD measurements showed that amyloid formation is more ef-
fective in the presence than in the absence of salt (cNaCl =
100 mm), with the preferred protein concentration ranging
from 80 to 160 mm, while the optimal pH is near 4.0. The amy-
loid thus produced showed a typical twisted fibril structure
(Figure 2).
The formation of these fibrils could not be followed by ThT
fluorescence and thus ECD spectra were recorded for each of
the 96 wells. Based on the results, additional experiments were
Figure 1. a) Primary sequence of E5 with residues colored by their charges
of pH 7.0: negatively charged amino acid, positively charged amino acid,
and neutral amino acid are highlighted with red, blue, and black, respective-
ly. b) Overall charge (z) of E5 as a function of the pH calculated by Prot pi
(http://www.protpi.ch). c) The solubility of E5 as a function of the pH (at
25 8C) shows that near the isoelectric point reversible precipitation occurs.
d) Folded structure of E5 (4 8C & pH 7.0) determined by NMR analysis, with
its four basic groups (highlighted blue), and five acidic groups (highlighted
red) with the following pKa values: SerC-terminal : 2.2, Gluside chain : 4.3, GluN-terminal :
9.1, Lysside chain : 10.8, and Argside chain : 12.5. e) The major microstates with their
labeling are depicted schematically at four different pH values of interest,
with side chains colored by charge: neutral (black), negative (red) and posi-
tive (blue).
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designed to identify parameters of amyloid formation sepa-
rately, to pinpoint their significance and specific molecular con-
sequences.
Optimum conditions located for E5 amyloid formation: the
temperature-scan
NMR (2D homonuclear) measurements were carried out to de-
termine the structure of E5 varying the temperatures between
4 and 48 8C (at pH 7, cprotein0.8 mm, cion0 mm) leading to
the primary conclusion that as temperature increases, partial
unfolding occurs without amyloid formation. We found that al-
though NMR frequencies shift with rising T, line broadening
only takes place above 37 8C, indicating that considerable un-
folding occurs only at 48 8C (Figure S1 in the Supporting Infor-
mation). The unsynchronized local backbone fluctuation of the
folded F-state enhances as T increases. Furthermore, we have
determined the most T-sensitive residues of E5 for which the
presence of hidden intermediate(s) (I-state(s))[36, 37] was re-
vealed. The thermal unfolding of the protein backbone shows
a nonlinear T dependence for Leu7, Ile9, and Lys13 and, to a
lesser extent, for Ala4, Val5, and Tyr8, indicating an enhanced
presence of transient conformers at higher temperatures for
the inner helix of E5 (Figure 1, Figure S2). 3D structure elucida-
tions were also completed by acquiring a large number of
NOE distance-restrains (Figure 3 and Table S1). Although the
total number of restrains drops as T increases, 666 (4 8C)!221
(48 8C), the latter number of NOEs are still sufficient to estab-
lish the overall 3D-fold of E5 even at 48 8C (especially since 16
out of 221 are key long-range restraints) (Figure 3 e and
Table S1). Inter-residue NOEs associated with Y8 and W11 (Fig-
ure S3) enabled us not only to determine the overall molecular
scaffold but also the relative orientation of the two aromatic
side chains. At 37 8C, 458 distance restraints in total, among
which 40 long range ones (i!(i + 5<)) were assigned, afford-
ing a single time-average and compact 3D structure for E5.
While the central a-helix is tightly folded at this temperature
(RMSD of the backbone heavy atoms is 0.64  within the 50
best-fit structures) (Table S1), as T increases the unfolding of
the -P17SSGRP22- segment was detected. This segment is the
least structured area within the folded scaffold even at 4 8C,
Figure 2. TEM images of E5 amyloid fibrils. Typical twisted amyloid fibrils
were observed. Most fibrils were bundled and formed supercoiled structure.
Scale bars: 500 nm.
Figure 3. a) Superimposed best 50 NMR structures of E5 at different pH
values and temperatures (conditions and the net charges explicitly shown
for each structure ensemble). The background color indicates the fold com-
pactness: green—unfolded, gray—folded, red—misfolded leading to amy-
loid formation. Aromatic side chains of the key Y8 and W11 are highlighted
magenta. The basic (N-terminal ; R6, K13, R21) moieties are protonated, the C-
terminal (S25) deprotonated, whereas the protonation microstates of the Glu
residues are shown at the right side at each pH. All atoms backbone RMSD
() as a function of the primary sequence of E5 at b) different temperatures
(8C) and c) different pH values are plotted. The total number of NOEs as-
signed for E5: SNOEi!(i + 1), SNOEi!(i + k) where k = 2,3,4, SNOEi!(i + 5<) are re-
ported as d) the temperature was scanned at pH 6.9 and e) as pH was
scanned at T = 15 8C.
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where only sequential NOEs could be measured (Figure 3 c).
Nevertheless, the large number of NOEs associated with Y8 and
W11 residues and the -P22PP24- segment ensures their concerted
motion, signaling that the hydrophobic core remains well-
structured at 37 8C and below (Figure S3).
Due to exchange phenomena, NMR spectroscopy cannot be
used to provide precise structural information at high T, there-
fore complementary FUV-ECD measurements were carried out
to follow the transition of the backbone fold up to 85 8C. The
recorded spectra were deconvoluted using the CCA + protocol
as mixtures of folded (F-) and unfolded (U-) forms.[38–40] At
lower temperatures, in line with the NMR data, the folded frac-
tion is dominant (F content goes from 100 to 80 % as T increas-
es from 5 to 35 8C), a 50:50 % mixture is reached near 60 8C,
while at 85 8C the spectrum indicates a 70 % unfolded content
(Figure S4).
The pH-scan
2D-NOESY driven 3D structure elucidation was completed (cE5
500–1500 mm, cNaCl <10 mm) at various pH values (6.9, 5.9,
5.0, 4.1, 2.0) at T = 15 8C (Figure 3 b) (The poorer signal to noise
ratio meant that longer measurement time was required at
pH 5.0 and 4.1). The solubility of E5 drops close to its isoelec-
tric point (pH 4.8, Figure 1) where unspecific and reversible
precipitation was observed. As side chain protonation pattern
varies with pH, H-bonds and other weak interactions also
change. E5 contains a protonated N-terminal (pKa = 9.1) plus
three basic residues, Arg6 (pKa = 12.5), Lys
13 (pKa = 10.8) and
Arg21 (pKa = 12.5), with an acidic C-terminal (pKa = 2.2) and four
acidic glutamines (Glu1, Glu2, Glu3 and Glu14) (pKa 4.25) (the
listed pKa values are nominal values that strongly depend on
backbone conformation). The net charge of E5 is predicted to
be positive at pH values smaller than 5 (Figure 1). At pH 7.0,
two salt bridges may contribute to the stabilization of the 3D-
fold, those of Glu1()$Arg6(+) and Glu14()$Arg21(+). But as
pH decreases, Glu(s) get partly (or completely) protonated and
thus salt bridges weaken and 3D-fold compactness loosens.
Accordingly, at pH 6.9, 5.9, and 5.0, the measured 3D structures
of E5 are similar (Figure 3), although conformational heteroge-
neity increases considerably (demonstrated by the reduction of
the total number of assigned restrains from 666 to 319; Fig-
ure 3 f and Table S1). Thus, the Trp-cage fold holds, though
backbone heavy atom RMSD of the 50 best structures increas-
es significantly: RMSD (pH 6.9, T = 15 8C) = 0.73  ! RMSD
(pH 5.0, T = 15 8C) = 2.56  (Table S1). We found that the total
number of NOESY cross-peaks between R21 and W11 residues is
a reliable measure of the Trp-cage fold compactness (Fig-
ure S3): 11 and 10 such peaks were assigned at pH 6.9 and 2.0,
but only 3 at 5>pH>4 (T = 15 8C). Moreover, RMSD changes
show that the a-helix becomes partly unfolded, as the pH gets
closer to 4.1 (Figure 3 d). The structure loosening effect of the
pH drop is the most pronounced between residues 13 and 21:
the 310-helix (-G
15GPSSG20-) tends to unwind, exposing both
the Y8 and W11 core residues to external water molecules
(Figure 3). Interestingly, moving beyond the isoelectric point,
ordering of the ensembles takes place and the original F-state
reappeared at pH 2.0. At pH 6.9, 77 long-range NOEi!(i + 5<) re-
straints were assigned, while at pH 2.0 in total 84 NOEsi!(i + 5<)
were found. This is rather unexpected since the overall charge,
as well as the local charge distribution of E5 is indeed different
at the above two pH values. Meanwhile, in between, at pH 4.9
only 22 NOEs of this kind were recorded (Figure 3 b). In conclu-
sion, the pH-scan shows that the basic topological features of
the Trp-cage fold of E5 (and other analogues[41]) are preserved
at pH 7.0 and 2.0, but weakened near the isoelectric point,
where I-states of full refolding potential or of amyloidogenic
misfolding capacity could be present simultaneously (Fig-
ure S5).
The effect of stirring
At pH 4.1 and T = 37 8C, in the absence of stirring or sonication,
the gradual decay of the far-UV ECD spectrum intensities of E5
was detected, which is indicative of self-association leading to
the loss of monomeric form or weakly bound low molecular
weight associates in the solution (Figure S6). Stirring, however,
greatly speeds up both the nucleation and fibril maturation
stages of amyloidogenesis. This affects aggregation by increas-
ing fragmentation and hence the number of free ends to sup-
port further fibril growth and possibly by increasing the
number of collisions occurring between monomers and/or
small oligomeric clusters.[42, 43]
Stirring the solution of E5 for 51 h (pH 4.1) resulted in a
strong B-type FUV-ECD spectrum, indicating a predominantly
b-pleated backbone structure.[44, 45] When setting the pH to 4.9,
4.4, and 3.0, “mixed” ECD spectra were recorded (B/C-type)
even after 51 h (Figure 4) signaling that, in solution, both heli-
cal and b-stranded structures are present, and amyloid forma-
Figure 4. a) FUV-ECD spectra of E5 recorded after 51 h of incubation time at
constant stirring (cE5 = 250 mm, cNaCl = 50 mm, T = 37 8C). If SQE5
pH 4.1 = + 2,
then a B-type ECD is detected, which is indicative of a b-sheet backbone
structure. However, if pH 7.0 (SQE5
pH 7.0 =1) or pH 2.1 (SQE5pH 2.1 = + 4.0) E5
remains folded (predominantly a-helical). b) Spectral deconvolution enables
the approximate [F] and [Amyloid] ratios to be determined as a function of
the net molecular charge: SQE5.
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tion is less complete. At pH 7 and pH 2, pure C-type ECD spec-
tra were measured (even when stirring), indicating that only a-
helical backbone structures are in solution and thus, these pH
values prevent amyloid formation. To quantify the extent of
the transition from the folded toward the amyloid-like phase,
deconvolution of a large collection of ECD spectra were carried
out (including T-dependent ECD curves of E5 and E0 as unfold-
ed model miniprotein[37]). In this way, we obtained three pure
component spectra: A C-type for a-helical conformation, a U-
type corresponding to the unstructured and a B-type signaling
b-stranded backbone conformation. More interestingly, a simi-
lar NUV-ECD spectrum analysis (see below) shows that this
transition is more complex than a simple a- to b-backbone
conformational shift. Complemented with dynamic light scat-
tering measurement data, we conclude that these NUV-ECD
spectral changes are associated with a gradual amyloid forma-
tion.
The overall path from the F- to the amyloid state is reported
using a barycentric coordinate system (Figure 5) in which the
gradual maturation of the amyloid as a function of time is vi-
sualized. At any point along the route, the ratio of the folded,
unfolded, and amyloid states can be calculated from the de-
convoluted spectral properties. As an example, the “mixed
state” of [pF(t = 5 h) = 0.26, pU(t = 5 h) = 0.50, pAmy(t = 5 h) = 0.24]
or simply (0.26, 0.5, 0.24) is shown on Figure 5 (see the “yellow
dot” in Figure 5 d).
By using this mapping technique, three phases of the amy-
loid formation of E5 could be differentiated as i) initially the
path runs parallel to the folded!unfolded axis, with no or
marginal contribution of the amyloid state, corresponding to a
misfolding phase, with the gradual accumulation of the unfold-
ed/misfolded forms. ii) During the second phase the route runs
parallel to the folded!amyloid axis, corresponding to the nu-
cleation phase. During this phase a critical concentration of
misfolded structures is reached, while the misfolded content
remains nearly constant. F-state diminishes while Amy-states
start to accumulate, iii) The third phase runs parallel to the un-
folded!amyloid axis, where no further reversible unfolding
takes place: the misfolded/unfolded structures are trapped by
the growing amyloids, which is the elongation phase of the E5
amyloidosis.
Fine-tuning cprotein and csalt affecting the amyloid formation
Although E5 can form amyloid at low salt (cNaCl<1 mm) and
high protein concentrations (cE5>5–15 mm),
[34] under these ex-
treme conditions amyloid formation is poorly reproducible. To
locate physiologically more relevant and controllable amyloi-
dogenic conditions on the DG = f(T,pH,cprotein,cion,t,) surface,
both cE5 and cNaCl variables had to be optimized at a sensible
concentration range: 250< cE5<800 mm and 12.5<cNaCl<
50 mm with T & pH set as: T = 37 8C & pH 4.1. Fine-tuning was
completed with the HANABI system in a concerted manner
leading to the identification of several concentration pairs for
which amyloid formed and the transition was reproducible;
namely, cE5 = 250 mm and cNaCl = 50 mm, cE5 = 500 mm and cNaCl =
Figure 5. a) The C-type FUV-ECD of E5 (F-state) gradually shifts as a function of time, as amyloid formation progresses (cE5 = 250 mm, cNaCl = 50 mm, pH 4.1, stir-
ring at T = 37 8C). The final B-type spectrum stands for the amyloid state (t = 51 h) composed of b-strands. b) An ensemble of the FUV-ECD spectra of E5 form-
ing amyloid (Panel A) was formed with those of the T-dependent E0[37]and E5 (5<T(8C)<85) and deconvoluted into three pure component spectra c) stand-
ing for the F (black), U (green), and amyloid (red) states. d) The CCA + resulted in the relative coefficients of these three pure ECD spectra and depicts the
amyloid formation path in a Barycentric coordinate system: for example after 5 h the ratio is 26 % F, 50 % U, and 24 % Amy state (yellow dot) (c.f. Figure S7).
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25 mm, cE5 = 800 mm and cNaCl = 12.5 mm (with the solution
constantly stirred) (Figure S8).
As protein concentration increases, amyloid formation be-
comes more complete: [Amy]cE5¼400 mm (t = 8 h) = 0.34,
[Amy]cE5¼800 mm (t = 8 h) = 0.61 even when salt concentration is
low and fixed at cNaCl = 12.5 mm (a condition more suitable for
NMR) (Figure 6 a, Figure S9).
The rate of amyloid formation was also probed at a fixed
protein concentration (e.g. , cE5 = 400 mm) with increasing salt
concentration (cNaCl : 0 mm, 12.5 mm, 25 mm, 50 mm) (Fig-
ure 6 b, Figure S10). We found that both misfolding and nucle-
ation occurs at a similar rate. However, during the elongation
phase clear differences were detected as a function of cNaCl.
Upon stirring for three days (t = 76 h) the amyloid ratio was
found to be higher if salt concentration was lower:
[Amy]cNaCl¼0 mm = 0.85, [Amy]cNaCl¼12:5 mm = 0.78, [Amy]cNaCl¼25 mm =
0.63, [Amy]cNaCl¼50 mm = 0.52. This finding, at first glance, could
suggest that the easy way to avoid amyloid formation—at
least for E5—is to use a high salt concentration. However, as
we only detect amyloids of limited size by ECD (those that
remain part of the solution), it is more likely that the larger salt
concentration speeds up amyloid maturation and thus, elimi-
nates shorter amyloid fragments from the solution—an as-
sumption more in line with the literature data. Moreover, at
the salt concentration used here (<100 mm), beside the
nature of the anion and cation, specific ion-binding to the
polypeptide chain was also shown to contribute to the rate of
amyloidosis.[46–48] This could well be the case for E5 also:
during MD simulations of the monomeric protein (both at
pH 7 and pH 4.1 in 0.15 m NaCl solution) ca. 10 % of the all ion-
protein interactions involved the charged residues of the
Glu14$Arg21 salt bridge, which might contribute to the loosen-
ing of the hydrophobic core of E5 (Figure S11), influencing the
ratio of the misfolded structures present.
Temperature-dependence revisited
The effect of temperature on the kinetics of amyloid formation
was revisited by using the fine-tuned conditions of amyloid
formation (cE5 = 250 mm, cNaCl = 50 mm and pH 4.1) (Figure 6 c,
Figure S12). We found that the process is slower and incom-
plete both at 23 8C and 47 8C, compared to that of the physio-
logical temperature (37 8C). It seems that at a high temperature
the increased thermal motion disfavors self-association:
[Amy]47 8C,51 h = 0.34 ! [Amy]37 8C,51 h = 0.86. At temperatures too
low, the Brownian motion is significantly slower and thus
fewer collisions occur and the misfolding propensity of E5 is
lowered (see NMR data above): [Amy]23 8C,51 h = 0.12.
Verifying amyloidosis: NUV-ECD measurements
Amyloid transformation was monitored from the viewpoint of
the Y8$W11 aromatic interaction by acquiring NUV-ECD data.
At pH 6 the characteristic positive band at 283 nm (over the
entire tested protein concentration range) is indicative of a
shifted face-to-face p–p interaction between the two aromatic
rings of the hydrophobic core of E5 (Figure 7 a). However, at
Figure 6. Amyloid formation completeness monitored by far-UV ECD as a
function of time with a) different protein (black: 800, claret : 400 mm) but
same ion concentration (12.5 mm) ; b) same protein (400 mm) and different
ion concentration (black: 50, claret : 25, green: 12.5, blue: 0 mm) ; c) same
protein (250 mm) and the same ion concentration (50 mm) at different tem-
peratures: T = 23 (claret), 37 (black), and 47 8C (green).
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pH 4.1 negative bands were detected in this spectral region
(270<l<290 nm) (Figure 7 b) and assigned to an edge-to-face
p-p interaction, signaling that misfolding of E5 concerns the
relative re-orientation of the two aromatic rings of the core.
However, as amyloid transformation proceeds, gradually these
negative bands are reverted and positive bands similar to
those measured for the folded state at a slightly shifted posi-
tion appear. As amyloid formation progresses, these bands in-
tensify : after 26 h, band intensities are about 10 times higher
than those of the initial F-state (V283 nm : 4000!40 000) (Fig-
ure 7 a and c). This side chain restructuring coincides with the
backbone changing from an a- to b-state. Thus, we propose
that the enhanced positive NUV-ECD bands between 270<l<
290 nm no longer arise from a pairwise, intramolecular shifted
face-to-face p–p interaction, but rather from the interstrand in-
teraction of Tyr and Trp side chains packed tighter in the
supramolecular assembly of the amyloid phase.
The nature of the misfolded states
Amyloid formation proceeds at physiological temperature, but
it can be quenched if cooled to 4 8C. Thus, a series of hetero-
nuclear correlation spectra (1H-15N-HSQC) were recorded at 4 8C
using samples retrieved at regular time intervals (every 30 min)
during amyloid formation (Figure S13).
The 1H,15N-chemical shifts of all residues were calculated by
using Equation (1):
DðtÞ ¼ p½ðdHðtÞÞ2þðdNðtÞ=6,51Þ2 ð1Þ
as function of the time (0< t<24 h). Residues of larger
changes than the average chemical shift (tendt0>0.047 ppm)
are those of the a-helix (E2, E3, V5, L7, I9, Q10, K13), signaling that
amyloid formation affects this region. Residues of the helix
were found to be the most temperature sensitive as well (Fig-
ure S2), indicating that this region is assailable as soon as the
shielding efficacy of the Trp-cage fold against water gets re-
duced. This region (segment -R6LYIQWL12-) was also predicted
to be the most amyloidogenic of the sequence by CamSol.[49]
Therefore, we propose that the a-helix itself is the seed of
amylogenic nucleation. As its misfolding and transient unwind-
ing allows the reorientation of the aromatic side chains, di-
and oligomers of the misfolded monomers can interact via
their exposed hydrophobic cores.
Amyloid formation is optimal at pH 4.1, where the overall
charge of E5 is near + 2 (Figures 1, 2, and 3) and thus, on aver-
age three out of the four Glu side chains are protonated. To
identify the most likely protonation state to trigger misfolding,
MD simulations were carried out. At pH 7 only one possible
protonation motif, that of E5[1E1,
2E1,
3E1,
14E1] exists, while at
















patterns have to be considered, which we will refer to as mi-
crostates. Conformational descriptors were selected to mea-
sure the extent of misfolding (see Methods, Table 1 and
Figure 8, Figure S14).
The simulations of four microstates provided equilibrium en-
sembles quite similar to that of the folded structure derived













14E0] . In contrast, a





ly different from any of the above when descriptors iix were
evaluated, this state shows strong resemblance to the loos-
ened NMR structural ensemble measured at pH 4.1. We found
Figure 7. NUV-ECD (240–325 nm) spectra reveal how conformers and inter-
action modes of Y8$W11 aromatic residues change as function of the pH
and time. At pH 4.1 b) the p–p interaction profile changes as protein con-
centration increases (84<cE5<730 mm at 25 8C, cNaCl0 mm), whereas it re-
mains unchanged a) at pH 6.0. c) NUV-ECD spectral shift signals indicating
the changing interaction mode of Y8 & W11 as function of the time
(0< t<26 h) during amyloid formation (cE5 = 800 mm, cNaCl = 12.5 mm, pH 4.1,
stirring at T = 37 8C).
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14E0] both d11W$17P, and
d11W$23P, distances are lengthened by 0.4 and 0.3 , respective-
ly, and in some conformers the d11W$21R distance shifted from
2.85 to 5.85 , indicating the appearance of less compact pro-
tein folds. Furthermore, as the distribution of m gets wider, the
-PPP24- segment twists more often with respect to the main
axes of the a-helix. In parallel, d8Y$11W increases by 0.9 . The
relative orientation of the aromatic side chains changes as
well : measured q shows a more diverse distribution relative to
the other microstates, while the values of a and f increase





protonation microstate has an enhanced backbone conforma-
tional freedom and a significantly rearranged hydrophobic
core, with respect to all the others. The Trp-cage gets occa-
sionally unfolded, giving rise to unshielded aromatics and ex-
posed backbone amide groups, ready for self-association and
subsequent amyloid formation (Figure S14), though these
events are transient, and misfolding is temporary. However, it
Table 1. Conformational measures introduced to signal the degree of misfolding of E5. Each measure type a critical value or critical interval was specified




Measure type Description of the measure Critical value of the measure
i d11W$17P distance between Trp
11 & Pro17 d11W$17P>5.7 
ii d11W$23P distance between Trp
11 & Pro23 d11W$23P>4.7 
iii d11W$21R distance between NH of Trp
11 and CO of Arg21 d11W$21R>6.0 
iv d14E$21R distance between donor of Arg
21 and acceptor of Glu14
v m torsion angle between the main axis of the core a-helix and of the polyPro of the C terminus m>458
vi d8Y$11W distance between Tyr
8 & Trp11 d8Y$11W>7.0 
vii a angle between the planes of the aromatic rings a>708




ix f azimuthal angle of the aromatic rings f>3208
Figure 8. The distributions of conformational measures introduced to signal the degree of misfolding of E5. a–d) The distribution of the selected measures for
the MD trajectories (gray: pH 7, E5[1E1,
2E1,
3E1,
















14E0] are plotted, whereas the distribution of the selected measures for NMR structures (green: pH 7, purple:
pH 4.1) are indicated for every structure above the MD distribution curves in a linear 1D manner. The measure of the E5[1E1,
2E0,
3E0,
14E0] microstate is slightly
different from the other microstates; moreover, a minor population of the E5[1E1,
2E0,
3E0,
14E0] microstate shows considerably distinct properties. Table 1 con-
tains a limit for each measure that can be used to distinguish/separate the divergent/misfolded population of the E5[1E1,
2E0,
3E0,
14E0] microstate. e) NMR calcu-
lated folded structure (gray), and f) one of the MD-based misfolded (blue) structures are shown to visualize the conformational differences. Additional distri-
butions of the selected measures are shown in Figure S15.
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should be noted that MD simulations carried out here consider
isolated molecules. The exposed aromatic and hydrophobic
side chains create a “sticky” interaction center for E5, quite as
the free b-edges that appear transiently on the surface of local-
ly misfolded large, globular proteins and become initiators of
aggregation. Thus, when collisions among similarly loosened
conformers of E5 are also considered, the described changes
might become sufficient to create the first di- and oligomer
nuclei of aggregates (Figure 9). These findings also explain
why stirring is necessary for amyloid formation of E5; given
that only one of the four possible protonation patterns of
pH 4.1 produces a “misfolded enough” conformer, a great
number of collisions are required for successful nucleation.
Building a model of the amyloid state
To obtain a picture of the amyloid state, MD simulations
were carried out for models of four-b-strand clusters














14E1])4 (four-stranded models were shown
to be sufficiently large for modeling aggregation nuclei in vari-
ous different systems[50–52]). We have probed three different rel-
ative offsets, namely that of “YI”, “YK”, and “YW” (Figure S16 A,
B, and C) for each.
From the three probed offsets, YW turned out to be both
the most stable at pH 4.1 and the most sensitive to pH shift
(since both at pH 2 and 7, the folded conformation is most
stable and practically no amyloid formation could be detected,
we expected the most realistic model to be significantly more
stable at pH 4.1) (Figure S17). Considering that in the -PPP24-
segment fPro must be ca. 608 and thus this part of the se-
quence is unlikely to form an extended b-sheet structure (with
f145, y + 1458), in case of the YW offset 18 pairs of in-
terstrand H-bonds could be formed between residue 1–18 in
total. In YWpH 4.1 on average 10 out of 18 H-bonds are present
during the MD simulation between the two middle chains, typ-
ically involving residue-pairs such as V5-E14, L7-L12, I9-Q10, W11-Y8,
and K13-R6. These interstrand H-bonds confirm that an aggrega-
tion core can indeed form between residues 5–14, as suggest-
ed above. Furthermore, in this arrangement of YWpH 4.1 an aro-
matic ladder forms between the Y8 and W11 side chains of adja-
cent b-strands, as they come in close proximity (d8Y$11W <6 
as measured between the center of the rings) (Figure S16 D).
The aromatic ladder enables the formation of the shifted face-
to-face p–p interaction expected based on ECD spectroscopic
data. Interestingly, the derived orientation and spacing of the
Tyr and Trp side chains here is also quite reminiscent of the ar-
omatic clusters created by mutations within the central single-
layer b-sheet of Borrelia outer surface protein A (OspA) to
probe the structure-ordering capacity of such residues.[53]
Using the mid-structures of six different clusters (see Meth-
ods) of the MD simulation of (E5 pH 4.1)4 YW as possible amyloid
seeds, we also probed different inter-sheet arrangements by
using a protein-protein docking algorithm. The near-parallel ar-
rangements thus obtained could be grouped into two funda-
mentally different topologies (using the nomenclature intro-
duced by Eisenberg and co-workers[54]): those of class 7 (equifa-
cial, antisymmetric, up-up) with translational symmetry, and
class 8 (antiparallel, equifacial, antisymmetric, up-down) with
twofold symmetry (Figure 10).
In the derived b-sheet-dimers, ((E5 pH 4.1)4)2, the average dis-
tance between the b-sheets separated by the zipper interface
varies between 10–12 , in line with the 8–10  experimental
values determined for various amyloid structures.[55–59] Further-
more, in this sandwich form, the intersheet aromatic side
chains may approach each other even closer than the intra-
sheet 6  described above (Figure S18). We found thatFigure 9. Possible self-aligning mode of a conformer of the MD simulation.
The antiparallel orientation of the helices is due to Coulombic interactions
operative at pH 4.1 in the selected microstate. Aromatic–aromatic (Y–W) in-
teraction driven backbone pairing of the misfolded molecules.
Figure 10. The two basic topologies found by docking (E5)4 amyloid seeds
are the antiparallel equifacial antisymmetric up–down (class 8) with a two-
fold symmetry and equifacial antisymmetric up–up (class 7) with translation-
al symmetry. The schematic illustrations of the basic amyloid layout shown
have the aromatic residues highlighted: above, Tyr: light-blue triangle and
Trp: dark-blue circle. Twisted amyloid b-sheets (below) and 908-rotated plus
enlarged view of the aromatic residues are shown in the middle: Tyr (light-
blue) and Trp (dark-blue) with oxygen atoms red and nitrogen (middle
blue). Red double arrows show the specific distance of the associated b-
sheets.
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(E5 pH 4.1)4 seeds with a slightly twisted backbone find partners
more readily to form the sandwich structure than those with
fully extended backbones, in accordance with the general view
that twisted filaments are more stable and thus more preva-
lent in nature.[60] These findings further support our model for
the aggregation of E5 as nucleated by the antiparallel oriented
b-sheets formed between the most aggregation-prone seg-
ment of the sequence, the -V5RLYIQWLK13- unit.
Conclusions
Concerning E5, the Exenatide variant studied here, we found
that its amyloid aggregation is most likely triggered by the
transiently exposed aromatic and hydrophobic side chains of
loosened—misfolded—conformers, which create a center for
intermolecular associations. The clusters thus created provide
stabilization (spatial closeness for sufficient time) for the much
slower process of a-helix to coil and then to extended b-
strand transition, which seems to be highly unfavorable for the
monomeric forms but eventually leads to the formation of a b-
structured amyloid nucleus. The amyloidosis of E5 thus follows
the nucleated growth mechanism.[42, 43]
Studying the early phases of amyloid formation is crucially
important both for understanding the initialization of various
pathophysiological processes and for aiding the design of non-
toxic peptide medications that will not become initiators of
such processes themselves. We derived a new monitoring
technique of amyloid progression that can be applied even if
the amyloid in question is ThT silent—using simple ECD meas-
urements. Decomposition of the spectra and its barycentric
representation on the folded-unfolded-amyloid potential
energy surface of the amyloidic transition can be applied to
filter out potentially harmful sequences from development.
Generally, it can be concluded that the lowest possible salt
concentration, low temperatures, and the absence of agitation
can prolong the shelf-life of any polypeptide and protein medi-
cations, but, somewhat disturbingly, we also found that the
optimum temperature for E5 amyloidosis coincides with our
body temperature and requires well below physiological salt
concentration. This just underlines how important it is to test
the aggregation propensity of any drug candidates.
Experimental Section
Protein expression and purification : The E5 miniprotein was pro-
duced by bacterial expression using the previously published pro-
tocol.[33]
Preparation of amyloid form of E5 miniprotein : The lyophilized
E5 samples were dissolved in distilled water. First, the pH of pro-
tein solution was adjusted to pH 7 with 0.1 m NaOH solution (Orion
Star A211 pH meter (Thermo Scientific)) then decreased to 4.1 or
lower (pH-dependent amyloid formation) with 0.1 m HCl solution.
Finally, desired NaCl concentration was adjusted with concentrated
NaCl solution. The protein solution was stirred (with magnetic stir-
rer) and incubated at target temperatures. At a given time, 10-fold
diluted sample was measured with ECD spectroscopy. The concen-
tration of the diluted sample was determined with a NanoDrop
Lite Spectrophotometer (Thermo Scientific) at 280 nm.
NMR experiments : Datasets were collected with a 16.4 T Bruker
Avance III spectrometer equipped with a 5 mm inverse TCI probe-
head with z-gradient. Spinlock (d9) for 1H-1H TOCSY was 80 ms,
while the mixing time (d8) of 150 ms was taken for 1H-1H NOESY
spectra. NMR structure calculations were performed and refined by
cooperative use of CcpNmr Analysis 2.4.1. , Aria 2.0[61] and CNS
Solve 1.2.[62]
Molecular dynamics simulations : MD simulation were carried out
as implemented in GROMACS59, using the AMBER-ff99SBildnp*
force field. The systems were solvated with TIP3P water molecules
in dodecahedral boxes with a size allowing 10  between any pro-
tein atom and the box. Trajectories of 600 ns ((E5)4 models) to
1000 ns (E5 monomers) NPT simulations with a 2 fs time step at
310 K and 328 K and 1 bar were collected (with snapshots at every
4 ps).
Electronic circular dichroism spectroscopy : Far- and near-UV ECD
measurements were carried out with a Jasco J810 spectrophotom-
eter. The temperature at the cuvette was controlled with a Peltier-
type heating system.
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The Route from the Folded to the
Amyloid State: Exploring the Potential
Energy Surface of a Drug-Like
Miniprotein
Centers of reorganization : The amyloid
formation of the folded segment of a
variant of Exenatide (a marketed drug
for type-2 diabetes mellitus) was stud-
ied by electronic circular dichroism
(ECD) and NMR spectroscopy. Results in-
dicate that the amyloid transition is trig-
gered by subtle misfolding of the a-
helix, exposing aromatic and hydropho-
bic side chains that may provide the
first centers for an intermolecular reor-
ganization.
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